Trial Watch: DNA vaccines for cancer therapy

Mostrar otras versiones (1)

During the past 2 decades, the possibility that preparations capable of eliciting tumor-specific immune responses would mediate robust therapeutic effects in cancer patients has received renovated interest. In this context, several approaches to vaccinate cancer patients against their own malignanci...

Descripción completa

Detalles Bibliográficos
Autores principales: Pol, Jonathan, Bloy, Norma, Obrist, Florine, Eggermont, Alexander, Galon, Jérôme, Hervé Fridman, Wolf, Cremer, Isabelle, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008456/
https://www.ncbi.nlm.nih.gov/pubmed/24800178
http://dx.doi.org/10.4161/onci.28185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008456/
https://www.ncbi.nlm.nih.gov/pubmed/24800178
http://dx.doi.org/10.4161/onci.28185

Ejemplares similares